Several clinical investigations have revealed that Nectin-4 can serve as a tumor biomarker, and its over-expression in cancer tissues is significantly associated with cancer progression and poorer prognosis of the patients [9, 11–13, 20, 23–25]. Here, NECTIN4 is linked to cancer.